Denali Therapeutics Inc. - COM (DNLI)

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Equity / COM
Number of holders
204
Total Shares
117M
Shares change
+6.16M
Total reported value, excl. options
$2.4B
Value change
+$121M
Put/Call ratio
0.98
Number of buys
104
Number of sells
-102
Price
$20.52
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.